These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1702216)

  • 1. Anti-Fas monoclonal antibody is cytocidal to human immunodeficiency virus-infected cells without augmenting viral replication.
    Kobayashi N; Hamamoto Y; Yamamoto N; Ishii A; Yonehara M; Yonehara S
    Proc Natl Acad Sci U S A; 1990 Dec; 87(24):9620-4. PubMed ID: 1702216
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokine-mediated induction of human immunodeficiency virus (HIV) expression and cell death in chronically infected U1 cells: do tumor necrosis factor alpha and gamma interferon selectively kill HIV-infected cells?
    Biswas P; Poli G; Orenstein JM; Fauci AS
    J Virol; 1994 Apr; 68(4):2598-604. PubMed ID: 7511175
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Increased human immunodeficiency virus (HIV) expression in chronically infected U937 cells upon in vitro differentiation by hydroxyvitamin D3: roles of interferon and tumor necrosis factor in regulation of HIV production.
    Locardi C; Petrini C; Boccoli G; Testa U; Dieffenbach C; Buttò S; Belardelli F
    J Virol; 1990 Dec; 64(12):5874-82. PubMed ID: 1700829
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1-infected myelomonocytic cells are resistant to Fas-mediated apoptosis: effect of tumor necrosis factor-alpha on their Fas expression and apoptosis.
    Okamoto M; Makino M; Kitajima I; Maruyama I; Baba M
    Med Microbiol Immunol; 1997 Jun; 186(1):11-7. PubMed ID: 9255761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Caspase inhibition activates HIV in latently infected cells. Role of tumor necrosis factor receptor 1 and CD95.
    Scheller C; Sopper S; Chen P; Flory E; Koutsilieri E; Racek T; Ludwig S; ter Meulen V; Jassoy C
    J Biol Chem; 2002 May; 277(18):15459-64. PubMed ID: 11854296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytocidal effect of tumor necrosis factor on cells chronically infected with human immunodeficiency virus (HIV): enhancement of HIV replication.
    Matsuyama T; Hamamoto Y; Soma G; Mizuno D; Yamamoto N; Kobayashi N
    J Virol; 1989 Jun; 63(6):2504-9. PubMed ID: 2470917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor.
    Yonehara S; Ishii A; Yonehara M
    J Exp Med; 1989 May; 169(5):1747-56. PubMed ID: 2469768
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin 1 induces HIV-1 expression in chronically infected U1 cells: blockade by interleukin 1 receptor antagonist and tumor necrosis factor binding protein type 1.
    Granowitz EV; Saget BM; Wang MZ; Dinarello CA; Skolnik PR
    Mol Med; 1995 Sep; 1(6):667-77. PubMed ID: 8529133
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
    Quirk SM; Porter DA; Huber SC; Cowan RG
    Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA fragmentation and cell death is selectively triggered in activated human lymphocytes by Fas antigen engagement.
    Owen-Schaub LB; Yonehara S; Crump WL; Grimm EA
    Cell Immunol; 1992 Mar; 140(1):197-205. PubMed ID: 1371242
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming tumor necrosis factor and drug resistance of human tumor cell lines by combination treatment with anti-Fas antibody and drugs or toxins.
    Morimoto H; Yonehara S; Bonavida B
    Cancer Res; 1993 Jun; 53(11):2591-6. PubMed ID: 7684321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The E1b oncogene of adenovirus confers cellular resistance to cytotoxicity of tumor necrosis factor and monoclonal anti-Fas antibody.
    Hashimoto S; Ishii A; Yonehara S
    Int Immunol; 1991 Apr; 3(4):343-51. PubMed ID: 1715182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Augmentation of cytotoxic effect of tumor necrosis factor on human immunodeficiency virus-infected cells by staurosporine, a potent protein kinase C inhibitor.
    Hamamoto Y; Matsuyama T; Yamamoto N; Kobayashi N
    Cancer Res; 1990 Sep; 50(17):5287-90. PubMed ID: 2386936
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fas ligand deficiency in HIV disease.
    Sieg S; Smith D; Yildirim Z; Kaplan D
    Proc Natl Acad Sci U S A; 1997 May; 94(11):5860-5. PubMed ID: 9159165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor necrosis factor alpha functions in an autocrine manner in the induction of human immunodeficiency virus expression.
    Poli G; Kinter A; Justement JS; Kehrl JH; Bressler P; Stanley S; Fauci AS
    Proc Natl Acad Sci U S A; 1990 Jan; 87(2):782-5. PubMed ID: 2300561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The monoclonal CD4 antibody M-T413 inhibits cellular infection with human immunodeficiency virus after viral attachment to the cell membrane: an approach to postexposure prophylaxis.
    Rieber EP; Federle C; Reiter C; Krauss S; Gürtler L; Eberle J; Deinhardt F; Riethmüller G
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10792-6. PubMed ID: 1438278
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effect of tumor necrosis factor-alpha and herpes simplex virus type 1 on the Tat-targeted inhibition of human immunodeficiency virus type 1 replication.
    Popik W; Pitha PM
    Virology; 1994 Aug; 202(2):521-9. PubMed ID: 8030218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppression of human immunodeficiency virus expression in chronically infected monocytic cells by glutathione, glutathione ester, and N-acetylcysteine.
    Kalebic T; Kinter A; Poli G; Anderson ME; Meister A; Fauci AS
    Proc Natl Acad Sci U S A; 1991 Feb; 88(3):986-90. PubMed ID: 1704137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibitory mechanism of anti-P30-52 monoclonal antibody against human immunodeficiency virus type 1 (HIV-1) multiplication in infected MT-4 cells.
    Ota A; Ueda S
    Hybridoma; 1999 Jun; 18(3):235-41. PubMed ID: 10475237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor necrosis factor enhances replication of human immunodeficiency virus (HIV) in vitro.
    Ito M; Baba M; Sato A; Hirabayashi K; Tanabe F; Shigeta S; De Clercq E
    Biochem Biophys Res Commun; 1989 Jan; 158(1):307-12. PubMed ID: 2912452
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.